BioNexus Gene Lab (BGLC) Capital Leases (2018 - 2026)
BioNexus Gene Lab recorded quarterly Capital Leases of $46605.0 in Q1 2026, up 257.92% quarter-over-quarter from $13021.0 in Q1 2022.
BioNexus Gene Lab's Capital Leases history runs 6 years deep, the most recent figure standing at $46605.0 for Q1 2026.
- In Q1 2026, Capital Leases changed N/A year-over-year to $46605.0; the TTM figure through Mar 2026 stood at $46605.0 (changed N/A YoY), while the FY2021 annual figure was $12803.0, down 63.72% from the prior year.
- Capital Leases came in at $46605.0 for Q1 2026 at BioNexus Gene Lab, up from $13021.0 in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $46605.0 in Q1 2026 to a low of $13021.0 in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46,605.00 |
| Mar 31, 2022 | 13,021.00 |
| Dec 31, 2021 | 12,803.00 |
| Sep 30, 2021 | 18,103.00 |
| Jun 30, 2021 | 23,610.00 |
| Mar 31, 2021 | 28,948.00 |
| Dec 31, 2020 | 35,292.00 |
| Sep 30, 2020 | 39,500.00 |
| Jun 30, 2020 | 38,366.00 |
| Mar 31, 2020 | 38,169.00 |
| Dec 31, 2019 | 45,086.00 |
| Sep 30, 2019 | 49,094.00 |
| Mar 31, 2019 | 58,825.00 |
| Dec 31, 2018 | 62,935.00 |